The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells

Nature Immunology

Volumn 12, Issue 10, 2011, Pages 975-983

  Norman, Jason M ^a   Mashiba, Michael ^b   McNamara, Lucy A ^a,b   Onafuwa Nuga, Adewunmi ^a   Chiari Fort, Estelle ^a   Shen, Wenwen ^a   Collins, Kathleen L ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CYTIDINE; GUANOSINE; LIGAND; URACIL; URIDINE;

ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; VIRUS INACTIVATION;

CELLS, CULTURED; CYTIDINE DEAMINASE; CYTOTOXICITY, IMMUNOLOGIC; DNA DAMAGE; GENE PRODUCTS, VPR; HIV; HUMANS; KILLER CELLS, NATURAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; T-LYMPHOCYTES; URIDINE;

EID: 80052966856     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2087     Document Type: Article

References (48)

1. Deeks, S.G. & Walker, B.D. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity 27, 406-416 (2007). (Pubitemid 47418678)
2. Peng, G., Lei, K.J., Jin, W., Greenwell-Wild, T. & Wahl, S.M. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J. Exp. Med. 203, 41-46 (2006).
3. Chiu, Y.-L. & Greene, W.C. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 26, 317-353 (2008). (Pubitemid 351600379)
4. Zhang, H. et al. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424, 94-98 (2003). (Pubitemid 36834848)
5. Bishop, K.N., Verma, M., Kim, E.-Y., Wolinsky, S.M. & Malim, M.H. APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog. 4, e1000231 (2008).
6. An, P. et al. APOBEC3G genetic variants and their influence on the progression to AIDS. J. Virol. 78, 11070-11076 (2004). (Pubitemid 39299647)
7. Yu, X. et al. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056-1060 (2003). (Pubitemid 37386201)
8. Kijak, G.H. et al. Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells. Virology 376, 101-111 (2008).
9. Jern, P., Russell, R., Pathak, V. & Coffin, J. Likely role of APOBEC3G-mediated G-to-A mutations in HIV-1 evolution and drug resistance. PLoS Pathog. 5, e1000367 (2009).
10. Goulder, P.J.R. & Watkins, D.I. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat. Rev. Immunol. 8, 619-630 (2008).
11. Schwartz, O., Maréchal, V., Le Gall, S., Lemonnier, F. & Heard, J.M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2, 338-342 (1996). (Pubitemid 26080655)
12. Collins, K.L., Chen, B.K., Kalams, S.A., Walker, B.D. & Baltimore, D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397-401 (1998). (Pubitemid 28093515)
13. Martin, M.P. et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39, 733-740 (2007). (Pubitemid 46848586)
14. Le Gall, S. et al. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8, 483-495 (1998). (Pubitemid 28196802)
15. Jennes, W. et al. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J. Immunol. 177, 6588-6592 (2006). (Pubitemid 44715020)
16. Martin, M.P. et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31, 429-434 (2002). (Pubitemid 35154456)
17. Morvan, M. et al. Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1+ NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells. J. Immunol. 182, 6727-6735 (2009).
18. Champsaur, M. & Lanier, L. Effect of NKG2D ligand expression on host immune responses. Immunol. Rev. 235, 267-285 (2010).
19. Fogli, M. et al. Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS Pathog. 4, e1000101 (2008).
20. Ward, J. et al. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog. 5, e1000613 (2009).
21. Schröfelbauer, B., Yu, Q., Zeitlin, S.G. & Landau, N.R. Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases. J. Virol. 79, 10978-10987 (2005). (Pubitemid 41170639)
22. Mansky, L.M., Preveral, S., Selig, L., Benarous, R. & Benichou, S. The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate. J. Virol. 74, 7039-7047 (2000). (Pubitemid 30470687)
23. Cerboni, C. et al. Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J. Gen. Virol. 88, 242-250 (2007). (Pubitemid 46085135)
24. Russell, R.A. & Pathak, V.K. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F. J. Virol. 81, 8201-8210 (2007). (Pubitemid 47101506)
25. Gasser, S., Orsulic, S., Brown, E. & Raulet, D. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436, 1186-1190 (2005). (Pubitemid 41232299)
26. Branzei, D. & Foiani, M. Regulation of DNA repair throughout the cell cycle. Nat. Rev. Mol. Cell Biol. 9, 297-308 (2008). (Pubitemid 351430844)
27. Hickson, I. et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 64, 9152-9159 (2004). (Pubitemid 39665530)
28. Mansky, L.M., Preveral, S., Selig, L., Benarous, R. & Benichou, S. The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 in vivo mutation rate. J. Virol. 74, 7039-7047 (2000). (Pubitemid 30470687)
29. Casartelli, N. et al. The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells. J. Exp. Med. 207, 39-49 (2009).
30. Gourzi, P., Leonova, T. & Papavasiliou, F.N. A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus. Immunity 24, 779-786 (2006). (Pubitemid 43867362)
31. Maasho, K., Opoku-Anane, J., Marusina, A.I., Coligan, J.E. & Borrego, F. NKG2D is a costimulatory receptor for human naive CD8+ T cells. J. Immunol. 174, 4480-4484 (2005).
32. Schrader, C.E., Linehan, E.K., Mochegova, S.N., Woodland, R.T. & Stavnezer, J. Inducible DNA breaks in Ig S regions are dependent on AID and UNG. J. Exp. Med. 202, 561-568 (2005). (Pubitemid 41186954)
33. Stenglein, M.D., Burns, M.B., Li, M., Lengyel, J. & Harris, R.S. APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat. Struct. Mol. Biol. 17, 222-229 (2010).
34. Altan-Bonnet, G. & Libchaber, A. Bubble dynamics in double-stranded DNA. Phys. Rev. Lett. 90, 138101 (2003).
35. Sire, J., Quérat, G., Esnault, C. & Priet, S. Uracil within DNA: an actor of antiviral immunity. Retrovirology 5, 45 (2008).
36. Priet, S. et al. HIV-1-associated uracil DNA glycosylase activity controls dUTP misincorporation in viral DNA and is essential to the HIV-1 life cycle. Mol. Cell 17, 479-490 (2005). (Pubitemid 40269113)
37. Yang, B., Chen, K., Zhang, C., Huang, S. & Zhang, H. Virion-associated uracil DNA glycosylase-2 and apurinic/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA. J. Biol. Chem. 282, 11667-11675 (2007). (Pubitemid 47100658)
38. Pauli, E.-K. et al. High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity. Retrovirology 6, 38 (2009).
39. Heil, F. et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526-1529 (2004). (Pubitemid 38314424)
40. Collins, K.L. & Baltimore, D. HIV's evasion of the cellular immune response. Immunol. Rev. 168, 65-74 (1999). (Pubitemid 29276673)
41. Lahm, H.W. & Stein, S. Characterization of recombinant human interleukin-2 with micromethods. J. Chromatogr. A 326, 357-361 (1985). (Pubitemid 15069382)
42. Schaefer, M.R., Wonderlich, E.R., Roeth, J.F., Leonard, J.A. & Collins, K.L. HIV-1 Nef targets MHC-I and CD4 for degradation via a final common beta-COP-dependent pathway in T cells. PLoS Pathog. 4, e1000131 (2008).
43. Qin, X.-F., An, D.S., Chen, I.S.Y. & Baltimore, D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. USA 100, 183-188 (2003). (Pubitemid 36078049)
44. Galbán, S. et al. Cytoprotective effects of IAPs revealed by a small molecule antagonist. Biochem. J. 417, 765-771 (2009).
45. Zhang, H. et al. Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. J. Virol. 78, 1718-1729 (2004). (Pubitemid 38176704)
46. Carter, C.C. et al. HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat. Med. 16, 446-451 (2010).
47. Nakai-Murakami, C. et al. HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination. Oncogene 26, 477-486 (2007). (Pubitemid 46160962)
48. Yamamoto, N. et al. Analysis of human immunodeficiency virus type 1 integration by using a specific, sensitive and quantitative assay based on real-time polymerase chain reaction. Virus Genes 32, 105-113 (2006). (Pubitemid 43357616)